Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Quince Therapeutics, Inc. | Director | Common Stock | 80.3K | $75.4K | $0.94 | Oct 23, 2023 | Direct |
Quince Therapeutics, Inc. | Director | Employee Stock Option (right to buy) | 27K | Jun 5, 2024 | Direct | ||
INTERCEPT PHARMACEUTICALS, INC. | Director | Common Stock | 0 | $19.00 | Nov 8, 2023 | Direct | |
INTERCEPT PHARMACEUTICALS, INC. | Director | Option to Purchase Common Stock | 0 | Nov 8, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
QNCX | Quince Therapeutics, Inc. | Jun 5, 2024 | 1 | $0 | 4 | Jun 7, 2024 | Director |
ICPT | INTERCEPT PHARMACEUTICALS, INC. | Nov 8, 2023 | 12 | -$638K | 4 | Nov 13, 2023 | Director |
QNCX | Quince Therapeutics, Inc. | Oct 23, 2023 | 1 | $0 | 4 | Oct 24, 2023 | Director |
QNCX | Quince Therapeutics, Inc. | Oct 23, 2023 | 0 | $0 | 3 | Oct 24, 2023 | Director |
ICPT | INTERCEPT PHARMACEUTICALS, INC. | May 24, 2023 | 2 | $0 | 4 | May 25, 2023 | Director |
ICPT | INTERCEPT PHARMACEUTICALS, INC. | May 25, 2022 | 2 | $0 | 4 | May 27, 2022 | Director |
ICPT | INTERCEPT PHARMACEUTICALS, INC. | May 27, 2021 | 2 | $0 | 4 | Jun 1, 2021 | Director |